Completed PHASE1 INTERVENTIONAL 1-arm NCT02009462

Artefill for the Treatment of HIV-associated Facial Lipoatrophy

Sponsor: Gerald Pierone, Jr. M.D.

Updated 8 times since 2017 Last updated: Jul 13, 2020 Started: Dec 31, 2013 Primary completion: Nov 30, 2019 Completion: Nov 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02009462, this PHASE1 trial focuses on HIV-facial Lipoatrophy and remains completed. Sponsored by Gerald Pierone, Jr. M.D., it has been updated 8 times since 2013, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Aug 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Aug 2019 — Aug 2020 [monthly]

Active Not Recruiting PHASE1

▶ Show 3 earlier versions

Jun 2018 — Aug 2019 [monthly]

Active Not Recruiting PHASE1
Feb 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gerald Pierone, Jr. M.D.
Suneva Medical, Inc.

Data source: AIDS Research and Treatment Center of the Treasure Coast

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vero Beach, United States